-
Our Mission
The mission of the ACTG Network
is to cure HIV and reduce the
burden of disease due to HIV
and its complications, including
tuberculosis and viral hepatitis. - ACTG Presentations at CROI 2019
- REPRIEVE: 7500 Participants Enrolled!
-
Learn more about ACTG Network clinical trials
- Open and Enrolling Studies
- Featured ACTG Publications
For Potential Study Participants
ACTG News & Meeting Information
Social Media
Featured Content
Guest Blog: Outreach, Recruitment and Retention Working Group Tips
A5366: Effects of SERM and HDACi on HIV-1
Peter Hunt, UC San Francisco, and Sara Gianella, UC San Diego, talk to us at the 2019 Retrovirus Conference in Seattle, about inflammation associated with CMV and HIV.